Jazz Pharma director uses 1,706 shares for taxes
A Jazz Pharmaceuticals director used 1,706 shares on August 31, 2026 to cover taxes from restricted stock unit vesting, not through an open-market sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jazz Pharmaceuticals plc (JAZZ) reported that director Rick E. Winningham had a total of 1,706 Ordinary Shares delivered or withheld on August 31, 2026 to satisfy tax obligations arising from the vesting of previously granted restricted stock units. These dispositions were not open-market sales and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Ordinary Shares F1 | 1,692 | $241.39 | $408K |
| Tax Withholding | Ordinary Shares F1 | 14 | $244.6443 | $3K |
Footnotes (1)
- F1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Key Figures
Key Terms
restricted stock units financial
vesting financial
tax obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity at JAZZ did Rick E. Winningham report on August 31, 2026?
Was a Rule 10b5-1 trading plan involved in Rick E. Winningham’s August 31, 2026 JAZZ transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.